Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q3 2025
Institutional positions in Verona Pharma plc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
VRNA is no longer listed, so this page shows Q3 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 243
- −47 vs. Q2 2025
- Shares held
- 80.4M
- +4.41M (+5.8%) vs. Q2 2025
- Total value
- $8.57B
- +$1.39B (+19.4%) vs. Q2 2025
- New holders
- 91
- 48 more added
- Sold out
- 138
- 79 more reduced
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 461,869 | $49.3M | 0.04% | −934,775−66.9% | Reduced |
| Oddo BHF Asset Management SAS | 467,471 | $49.9M | 1.90% | +222,113+90.5% | Added |
| Westchester Capital Management, LLC | 483,655 | $51.6M | 2.68% | +483,655 | New |
| Highbridge Capital Management LLC | 500,000 | $53.4M | 2.70% | +500,000 | New |
| Twin Securities, Inc. | 501,113 | $53.5M | 26.94% | +501,113 | New |
| CNH Partners LLC | 513,778 | $54.8M | 1.39% | +513,778 | New |
| Verition Fund Management LLC | 517,012 | $55.2M | 0.31% | +503,969+3,863.9% | Added |
| Perceptive Advisors LLC | 524,088 | $55.9M | 1.62% | −4,983,503−90.5% | Reduced |
| Highland Capital Management Fund Advisors, L.P. | 584,601 | $62.4M | 5.55% | +584,601 | New |
| Aisling Capital Management LP | 615,352 | $65.7M | 14.39% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 615,900 | $65.7M | 0.09% | +468,500+317.8% | Added |
| Affinity Asset Advisors, LLC | 625,000 | $66.7M | 6.21% | +15,000+2.5% | Added |
| Magnetar Financial LLC | 628,260 | $67.0M | 0.41% | +628,260 | New |
| TIG Advisors, LLC | 635,267 | $67.8M | 4.19% | +635,267 | New |
| Eventide Asset Management, LLC | 680,929 | $72.7M | 1.19% | −2,034,395−74.9% | Reduced |
| Alliancebernstein L.P. | 718,343 | $76.7M | 0.02% | +596,752+490.8% | Added |
| Bank of America Corp | 721,212 | $77.0M | 0.01% | +267,936+59.1% | Added |
| Qube Research & Technologies Ltd | 811,841 | $86.6M | 0.12% | +492,120+153.9% | Added |
| Vivaldi Asset Management, LLC | 909,123 | $97.0M | 6.26% | +909,123 | New |
| Omni Event Management Ltd | 962,341 | $102.7M | 11.86% | +962,341 | New |
| Polar Asset Management Partners Inc. | 970,000 | $103.5M | 2.10% | +958,400+8,262.1% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 1,002,080 | $106.9M | 2.72% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 1,010,564 | $107.8M | 0.05% | −5,123,841−83.5% | Reduced |
| Alpine Associates Management Inc. | 1,157,050 | $123.5M | 7.52% | +1,157,050 | New |
| Syquant Capital SAS | 1,208,312 | $128.9M | 37.01% | +1,208,312 | New |
| Vivo Capital, LLC | 1,393,432 | $148.7M | 11.97% | 00.0% | Unchanged |
| Barclays PLC | 1,393,716 | $148.7M | 0.05% | +1,283,105+1,160.0% | Added |
| JPMorgan Chase & Co | 1,414,770 | $151.0M | 0.01% | +1,058,163+296.7% | Added |
| Whitebox Advisors LLC | 1,566,501 | $167.2M | 3.11% | +1,566,501 | New |
| Morgan Stanley | 1,575,904 | $168.2M | 0.01% | +1,393,574+764.3% | Added |
| Summit Partners Public Asset Management, LLC | 1,785,407 | $190.5M | 6.20% | −358,879−16.7% | Reduced |
| Millennium Management LLC | 1,796,738 | $191.7M | 0.15% | +1,419,570+376.4% | Added |
| Balyasny Asset Management LLC | 1,863,426 | $198.8M | 0.40% | +1,269,777+213.9% | Added |
| Goldman Sachs Group Inc | 1,935,278 | $206.5M | 0.03% | −682,019−26.1% | Reduced |
| NEA Management Company, LLC | 2,252,994 | $240.4M | 13.19% | −10,144−0.4% | Reduced |
| Glazer Capital, LLC | 3,205,878 | $342.1M | 11.49% | +3,205,878 | New |
| Davidson Kempner Capital Management LP | 3,271,623 | $349.1M | 4.88% | +3,271,623 | New |
| Frazier Life Sciences Management, L.P. | 3,383,950 | $361.1M | 10.82% | 00.0% | Unchanged |
| FIL Ltd | 3,488,500 | $372.3M | 0.29% | +3,488,500 | New |
| BlackRock, Inc. | 3,826,710 | $408.3M | 0.01% | +3,483,014+1,013.4% | Added |
| HBK Investments L P | 4,263,576 | $455.0M | 6.70% | +4,263,576 | New |
| UBS Oconnor LLC | 4,283,462 | $457.1M | 13.74% | +4,283,462 | New |
| Pentwater Capital Management LP | 5,300,000 | $565.6M | 5.08% | +5,300,000 | New |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −4,129,618−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −3,051,878−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −1,810,000−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −1,789,513−100.0% | Sold out |
| Caligan Partners LP | 0 | $0 | 0.00% | −1,436,878−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,146,095−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −1,075,662−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −875,000−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −839,159−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −816,715−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −653,118−100.0% | Sold out |
| Westfield Capital Management Co LP | 0 | $0 | 0.00% | −539,813−100.0% | Sold out |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −521,859−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −526,296−100.0% | Sold out |
| Castle Hook Partners LP | 0 | $0 | 0.00% | −372,795−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −365,258−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −358,297−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −338,360−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −337,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −312,386−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −309,988−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −279,652−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −230,668−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −225,582−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −223,843−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −216,578−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −216,400−100.0% | Sold out |
| Tyro Capital Management LLC | 0 | $0 | 0.00% | −214,719−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −198,845−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −197,898−100.0% | Sold out |
| GW&K Investment Management, LLC | 0 | $0 | 0.00% | −193,782−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −179,200−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −160,701−100.0% | Sold out |
| Castleark Management LLC | 0 | $0 | 0.00% | −153,020−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −146,831−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −126,595−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −118,578−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −112,011−100.0% | Sold out |
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −106,500−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −102,977−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −98,742−100.0% | Sold out |
| 1492 Capital Management LLC | 0 | $0 | 0.00% | −98,057−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −95,000−100.0% | Sold out |
| Artisan Partners Limited Partnership | 0 | $0 | 0.00% | −86,101−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −85,141−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −76,131−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −68,982−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −59,985−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −57,505−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −56,326−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −49,322−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −49,302−100.0% | Sold out |
| HealthInvest Partners AB | 0 | $0 | 0.00% | −47,100−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −46,722−100.0% | Sold out |